Outcomes in treatment of infantile spasms with pulse methylprednisolone.
The authors report their experience with intravenous methylprednisolone for the treatment of infantile spasms. A pulse dose of 20 mg/kg intravenous methylprednisolone on each of 3 successive days, followed by a 2-month oral prednisolone taper, led to the rapid remission (range, 2-6 days) of infantile spasms in 5 of 10 (50%) infants. In the subgroup of infants treated within 1 month of onset, 5 of 6 (83%) experienced remission within 6 days. The authors estimate the medication cost of intravenous methylprednisolone with prednisolone taper to be less than $200. In comparison, the cost of a typical course of adrenocorticotropic hormone in the United States can exceed $70,000. Initial treatment with intravenous methylprednisolone and/or oral corticosteroids is a reasonable cost-effective approach to infantile spasms. The lack of serious side effects, low cost, availability, ease of administration, and comparable efficacy suggests that intravenous methylprednisolone merits consideration for study in randomized prospective trials.
Department of Neurology, University of Virginia Health System, Charlottesville, Virginia 22908, USA.
John R
JR
Mytinger
Mark
M
Quigg
William C
WC
Taft
Marcia L
ML
Buck
Robert S
RS
Rust
D000284:Administration, Oral; D000324:Adrenocorticotropic Hormone / Q000191:economics / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000191:economics; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000191:economics; D017063:Outcome Assessment, Health Care / Q000379:methods; D020551:Pulse Therapy, Drug / Q000379:methods; D013036:Spasms, Infantile / Q000188:drug therapy* / Q000191:economics / Q000503:physiopathology; D016896:Treatment Outcome
D005938:Glucocorticoids; D000324:Adrenocorticotropic Hormone; D008775:Methylprednisolone